(Q38130756)

29 August 2017

title

AT1 antagonists: a patent review (2008 - 2012). (English)

1 reference

29 August 2017

author

Thomas Mavromoustakos

series ordinal

1

object named as

Thomas Mavromoustakos

1 reference

29 August 2017

3

Serdar Durdagi

1 reference

29 August 2017

George Agelis

2

1 reference

29 August 2017

language of work or name

English

0 references

publication date

23 August 2013

1 reference

Expert Opinion on Therapeutic Patents

29 August 2017

published in

1 reference

29 August 2017

volume

23

1 reference

29 August 2017

issue

11

1 reference

29 August 2017

page(s)

1483-1494

1 reference

Angiotensin II receptors and drug discovery in cardiovascular disease

29 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.830104

Targeting the renin-angiotensin-aldosterone system in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.830104

Key developments in renin-angiotensin-aldosterone system inhibition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.830104

Angiotensin II receptor type 1 (AT1) selective nonpeptidic antagonists--a perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.830104

21 January 2018

ARB and cardioprotection

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.830104

Emerging drugs which target the renin-angiotensin-aldosterone system

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.830104

Angiotensin II and inflammation: the effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockade

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.830104

An efficient synthesis of a rationally designed 1,5 disubstituted imidazole AT(1) angiotensin II receptor antagonist: reorientation of imidazole pharmacophore groups in losartan reserves high receptor affinity and confirms docking studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.830104

Rational design, efficient syntheses and biological evaluation of N,N'-symmetrically bis-substituted butylimidazole analogs as a new class of potent Angiotensin II receptor blockers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.830104

Novel paramagnetic AT1 receptor antagonists.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.830104

Peroxisome proliferator-activated receptor-γ activation with angiotensin II type 1 receptor blockade is pivotal for the prevention of blood-brain barrier impairment and cognitive decline in type 2 diabetic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.830104

A systematic comparison of the properties of clinically used angiotensin II type 1 receptor antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.830104

Identification of telmisartan as a unique angiotensin II receptor antagonist with selective PPARgamma-modulating activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.830104

Angiotensin type 1 receptor blockers induce peroxisome proliferator-activated receptor-gamma activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.830104

Fimasartan, a novel angiotensin II receptor antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.830104

Angiotensin II type 1 receptor blockers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.830104

Comparative study of the AT₁ receptor prodrug antagonist candesartan cilexetil with other sartans on the interactions with membrane bilayers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.830104

Thermal, dynamic and structural properties of drug AT1 antagonist olmesartan in lipid bilayers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.830104

Comparative biophysical studies of sartan class drug molecules losartan and candesartan (CV-11974) with membrane bilayers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.830104

Interactions of the AT1 antagonist valsartan with dipalmitoyl-phosphatidylcholine bilayers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.830104

Antihypertensive drug valsartan in solution and at the AT1 receptor: conformational analysis, dynamic NMR spectroscopy, in silico docking, and molecular dynamics simulations

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.830104

The discovery of new potent non-peptide Angiotensin II AT1 receptor blockers: a concise synthesis, molecular docking studies and biological evaluation of N-substituted 5-butylimidazole derivatives

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.830104

Development of accurate binding affinity predictions of novel renin inhibitors through molecular docking studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.830104

Application of 3D QSAR CoMFA/CoMSIA and in silico docking studies on novel renin inhibitors against cardiovascular diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2013.830104

10.1517/13543776.2013.830104

21 January 2018

Identifiers

DOI

1 reference

29 August 2017

1 reference